BODE JOHN B purchased 10K shares of ZEVRA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $50.4K. The strongest form of insider conviction signal.
P · 6 purchases
Filed: 5/19/2023ACC: 0001437749-23-015335
+10K
Net shares
Net buyer
$50.4K
Total acquired
6
Open market trades
6B · 0S
6
Total transactions
10K acquired
Non-Derivative Transactions6
Common Stock
Direct
Shares
+1.39K
Price / share
$5.04
Trade value
$7K
% of position
New position
5/18/2023
0.00→1.39K
Common Stock
Direct
Shares
+300.00
Price / share
$5.04
Trade value
$1.51K
% of position
21.6%
5/18/2023
1.39K→1.69K
Common Stock
Direct
Shares
+1K
Price / share
$5.04
Trade value
$5.04K
% of position
59.2%
5/18/2023
1.69K→2.69K
Common Stock
Direct
Shares
+4.76K
Price / share
$5.04
Trade value
$23.99K
% of position
176.9%
5/18/2023
2.69K→7.45K
Common Stock
Direct
Shares
+100.00
Price / share
$5.04
Trade value
$504.50
% of position
1.3%
5/18/2023
7.45K→7.55K
Common Stock
Direct
Shares
+2.45K
Price / share
$5.05
Trade value
$12.38K
% of position
32.5%
5/18/2023
7.55K→10K
Total
Net shares
+10K
Net value
$50.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/18/2023 | P · Purchase | +1.39K | $5.04 | $7K | New position | 0.00 | 1.39K |
| Common Stock Direct | 5/18/2023 | P · Purchase | +300.00 | $5.04 | $1.51K | 21.6% | 1.39K | 1.69K |
| Common Stock Direct | 5/18/2023 | P · Purchase | +1K | $5.04 | $5.04K | 59.2% | 1.69K | 2.69K |
| Common Stock Direct | 5/18/2023 | P · Purchase | +4.76K | $5.04 | $23.99K | 176.9% | 2.69K | 7.45K |
| Common Stock Direct | 5/18/2023 | P · Purchase | +100.00 | $5.04 | $504.50 | 1.3% | 7.45K | 7.55K |
| Common Stock Direct | 5/18/2023 | P · Purchase | +2.45K | $5.05 | $12.38K | 32.5% | 7.55K | 10K |
| Total | +10K | $50.42K | ||||||
Derivative Transactions0
No derivative transactions reported